References:
- Zhou Y, Zhang J. Arthrogryposis-renal dysfunction-cholestasis (ARC)
syndrome: from molecular genetics to clinical features. Ital J
Pediatr. 2014;40: 77.
- Del Brío Castillo R, Squires JE, McKiernan PJ. A novel mutation in
VPS33B gene causing a milder ARC syndrome phenotype with prolonged
survival. JIMD Rep. 2019;47: 4–8.
- Agawu A, Sheppard S, Lin HC. A Novel VPS33B Mutation Causing a Mild
Phenotype of Arthrogryposis, Renal dysfunction, and Cholestasis
Syndrome. J Pediatr Gastroenterol Nutr. 2019;69: e55–e56.
- Agakidou E, Agakidis C, Kambouris M, Printza N, Farini M, Vourda E, et
al. A Novel Mutation of VPS33B Gene Associated with Incomplete
Arthrogryposis-Renal Dysfunction-Cholestasis Phenotype. Case Rep
Genet. 2020;2020: 8872294.
- Li L-T, Zhao J, Chen R, Wang J-S. Two novel VPS33B mutations in a
patient with arthrogryposis, renal dysfunction and cholestasis
syndrome in mainland China. World J Gastroenterol. 2014;20: 326–329.
- Taha D, Khider A, Cullinane AR, Gissen P. A novel VPS33B mutation in
an ARC syndrome patient presenting with osteopenia and fractures at
birth. Am J Med Genet A. 2007;143A: 2835–2837.